XML 87 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 264,538 $ 392,446
Prepaid expenses 0 377,780
Cash and marketable securities held in Trust Account 29,728,990 0
Total Current Assets 29,993,528 770,226
Cash and marketable securities held in Trust Account 7,372,451 309,790,455
TOTAL ASSETS 37,365,979 310,560,681
Current liabilities    
Accrued expenses 469,268 1,243,172
Excise tax payable 3,062,004 0
Accrued offering costs 5,000 75,000
Income taxes payable 308,194 823,991
Common stock to be redeemed (2,768,301 shares of Series A common stock) 29,728,990 0
Total Current Liabilities 35,388,456 2,142,163
Deferred underwriting fee payable 10,500,000 10,500,000
Total Liabilities 45,888,457 12,642,163
Commitments (Note 6)
Series A common stock subject to possible redemption; 667,391 and 30,000,000 shares issued and outstanding at December 31, 2023 and 2022 at redemption value of $10.93 and $10.30 per share, respectively 7,292,641 309,097,930
Stockholders' Deficit    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (15,815,868) (11,180,162)
Total Stockholders' Deficit (15,815,118) (11,179,412)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 37,365,979 310,560,681
Related party [Member]    
Current liabilities    
Extension promissory note - related party 160,000 0
Advance from related parties 1,655,000 0
Series A common stock [Member]    
Current liabilities    
Common stock to be redeemed (2,768,301 shares of Series A common stock) 29,728,990  
Stockholders' Deficit    
Common Stock 749 0
Series B common stock [Member]    
Stockholders' Deficit    
Common Stock $ 1 $ 750